Results 1 to 10 of about 2,585 (153)
Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer [PDF]
Journal of Fungi, 2021 Although breakthrough mucormycosis (BT-MCR) is known to develop on mold-active antifungals without Mucorales activity, it can also occur while on Mucorales-active antifungals.
Dierdre B. Axell-House +7 more
doaj +3 more sources
Innate and Adaptive Immunity to Mucorales [PDF]
Journal of Fungi, 2017 Mucormycosis is an invasive fungal infection characterised by rapid filamentous growth, which leads to angioinvasion, thrombosis, and tissue necrosis. The high mortality rates (50–100%) associated with mucormycosis are reflective of not only the aggressive nature of the infection and the poor therapeutics currently employed, but also the failure of the
Harlene Ghuman, Kerstin Voelz
openaire +5 more sources
Two New Species in the Family Cunninghamellaceae from China
Mycobiology, 2021 The species within the family Cunninghamellaceae are widely distributed and produce important metabolites. Morphological studies along with a molecular phylogeny based on the internal transcribed spacer (ITS) and large subunit (LSU) of ribosomal DNA ...
Heng Zhao +9 more
doaj +1 more source
Frontiers in Cellular and Infection Microbiology, 2023 BackgroundIn this study, we used real-time quantitative PCR (RQ-PCR) to rapidly detect Mucorales and Aspergillus in formalin-fixed, paraffin-embedded (FFPE) samples, targeting 18SrRNA gene and 28SrRNA gene. Identification of Mucorales and Aspergillus was
Xiaolin Jiang +3 more
doaj +1 more source
An Emergent Entity: Indolent Mucormycosis of the Paranasal Sinuses. A Multicenter Study
International Archives of Otorhinolaryngology, 2019 Introduction Indolent or chronic mucormycosis is a rare entity that affects both immunosuppressed and immunocompetent individuals. Additionally, its clinical evolution is nonspecific and there is no standardized treatment for this condition.
Erika Celis-Aguilar +11 more
doaj +1 more source
Animal Models to Study Mucormycosis
Journal of Fungi, 2019 Mucormycosis is a rare but often fatal or debilitating infection caused by a diverse group of fungi. Animal models have been crucial in advancing our knowledge of mechanisms influencing the pathogenesis of mucormycoses, and to evaluate therapeutic ...
Ilse D. Jacobsen
doaj +1 more source
Special Issue: Mucorales and Mucormycosis [PDF]
Journal of Fungi, 2019 Mucormycosis is a life-threatening infection, occurring mainly in immunocompromised patients, but also in immunocompetent patients after traumatic injuries [...]
Dannaoui, Eric, Lackner, Michaela
openaire +4 more sources
High-Temperature-Tolerant Fungus and Oomycetes in Korea, Including Saksenaea longicolla sp. nov.
Mycobiology, 2021 Global temperatures are steadily increasing, leading to significant changes in microbial diversity and ecology. In the present study, we isolated high-temperature-growing fungi and fungi-like group (Oomycota) strains from freshwater environments of Korea
Bora Nam, Dong-Jae Lee, Young-Joon Choi
doaj +1 more source
Mucormycosis and acute kidney injury [PDF]
Journal of Nephropathology, 2012 Mucormycosis, although said to be less common than candidiasis and aspergillosis is becoming increasingly associated with many co-morbid conditions and immunosuppression.
Krishan L Gupta, Aakriti Gupta
doaj +1 more source
MALDI-TOF-MS for Rapid Detection of Fungi causing Mucormycosis during COVID-19 Pandemic from a Tertiary Care Hospital in Southern India: A Retrospective Cohort Study [PDF]
Journal of Clinical and Diagnostic Research, 2023 Introduction: Mucormycosis is an opportunistic fungal infection that became a public health emergency during the second wave of Coronavirus Disease-2019 (COVID-19).
R SOMESHWARAN, B APPALARAJU
doaj +1 more source